Safi Landskroner
Pharmaceuticals
MAPI Group
Israel
Biography
Safi Landskroner has served as our vice president of business development and regulatory affairs since October 2013. Ms. Landskroner has experience in developing new business and a proven track record in international regulatory affairs. From 2012 until 2013, Ms. Landskroner served as the head of the procurement division of Meuhedet Sick Fund. From 2009 until 2011, Ms. Landskroner served as business development consultant (a vice president position) of Neopharm Ltd. Ms. Landskroner currently serves as a director of Therapix Biosciences Ltd. (TASE:TRPX). Ms. Landskroner previously served as research development project manager and later as vice president of business development and regulatory affairs, of Dexcel Pharma Ltd. Ms. Landskroner holds an MBA from Bradford University, UK, and a BPharm from the Hebrew University in Jerusalem, Israel.
Research Interest
business development
